Triochem Products P/B Ratio
Current P/B Ratio
0.04
Low Valuation
Very Low - Significant discount to book value, potential distress or value opportunity
Triochem Products (TRIPR) P/B ratio is 0.04 (Low), book value per share ₹ vs Healthcare average P/B of 0.01 — Very Low - Significant discount to book value, potential distress or value opportunity. View TRIPR 52-week chart for the annual high/low range and current price position.
Current Valuation Metrics
P/B Ratio
0.04
Current Price
₹17.39
Book Value/Share
₹
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
0.01
Sector Median
0.62
Sector Rank
#10 of 50
Sector Percentile
20.0%
TRIPR P/B Ratio — Valuation Insights & Book Value Analysis
Triochem Products price-to-book ratio interpretation, valuation status and historical context — current P/B 0.04 (Low). Review Triochem Products price earnings to evaluate earnings-based valuation against sector peers.
- Stock appears undervalued with PB of 0.04, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Trading at premium to sector average PB of 0.01
TRIPR vs Healthcare Peers — P/B Ratio Comparison
Triochem Products P/B 0.04 vs Healthcare average 0.01, median 0.62 — range -6.55–1.14.
Sector Average
0.01
Sector Median
0.62
Lowest P/B
-6.55
Highest P/B
1.14
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.14 | ₹70 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.74 | ₹118 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.16 | ₹43 | Low |
| Murae Organisor | MURAE | 0.2 | ₹41 | Low |